You are here
Different monitoring for different patients
Considering the wide range of IBD disease severity from benign to aggressive forms, apt monitoring according to severity, drugs and patient needs was recommended by Peter Irving. The importance of multidisciplinary networks of allied healthcare professionals was underlined. When all drugs fail, reviewing old therapies and checking for adherence are advised.